ImmuPharma plc (LON:IMM – Get Free Report)’s stock price rose 5.6% during trading on Wednesday . The stock traded as high as GBX 4.44 and last traded at GBX 4.44. Approximately 110,458 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 3,109,149 shares. The stock had previously closed at GBX 4.20.
ImmuPharma Trading Up 5.6%
The firm’s 50-day moving average price is GBX 5.17 and its 200 day moving average price is GBX 6.80. The company has a market capitalization of £27.67 million, a price-to-earnings ratio of -4.98 and a beta of 2.98.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
See Also
- Five stocks we like better than ImmuPharma
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
